Clinical Trial

Investigation of Medial Longitudinal Arch and Foot Function in Patients With Lipedema

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 2, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Lipedema is a chronic adipose tissue disorder that commonly leads to joint laxity, hypermobility, and functional limitations, yet its impact on foot morphology has not been systematically examined. This case-control study aims to investigate whether patients with lipedema exhibit a higher prevalence of generalized joint hypermobility and foot structural abnormalities-specifically pes planus-compared with age- and BMI-matched controls. Using radiographic measurements (Meary angle and calcaneal inclination angle), clinical hypermobility assessment, and validated functional scales, the study seeks to determine the relationship between lipedema, hypermobility, and foot function.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-07; most recent amendment 2025-12-31.
Status change: Not Yet Recruiting → Recruiting 2025-12-31
Trial Details
NCT Number NCT07294014
Lead Sponsor Marmara University
Conditions Lipedema, Hypermobility Syndrome (Disorder), Pes Planus, Joint Hypermobility
Enrollment 32 participants
Start Date 2026-01-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-02